Malaria vaccines
    1.
    发明授权
    Malaria vaccines 失效
    疟疾疫苗

    公开(公告)号:US07655247B2

    公开(公告)日:2010-02-02

    申请号:US12006784

    申请日:2008-01-03

    IPC分类号: A61K39/015

    摘要: The invention provides isolated placental P. falciparum polypeptides comprising an amino acid sequence selected from the group consisting of SEQ ID NOs:1-4 and 6-24, and immunogenic derivatives thereof. The invention also provides isolated nucleic acid molecules encoding the placental P. falciparum polypeptides of the invention, compositions comprising one or more placental P. falciparum polypeptides of the invention, methods for inducing an immune response against the placental P. falciparum polypeptides, and methods for treating and diagnosing placental malaria.

    摘要翻译: 本发明提供了分离的胎盘恶性疟原虫多肽,其包含选自SEQ ID NO:1-4和6-24的氨基酸序列及其免疫原性衍生物。 本发明还提供编码本发明的胎盘恶性疟原虫多肽的分离的核酸分子,包含本发明的一种或多种胎盘恶性疟原虫多肽的组合物,用于诱导针对胎盘恶性疟原虫多肽的免疫应答的方法,以及用于 治疗和诊断胎盘疟疾。

    Malaria vaccines
    2.
    发明授权
    Malaria vaccines 失效
    疟疾疫苗

    公开(公告)号:US08012493B2

    公开(公告)日:2011-09-06

    申请号:US12633474

    申请日:2009-12-08

    IPC分类号: A61K39/015

    摘要: The invention provides isolated placental P. falciparum polypeptides comprising an amino acid sequence selected from the group consisting of SEQ ID NOs:1-4 and 6-24, and immunogenic derivatives thereof. The invention also provides isolated nucleic acid molecules encoding the placental P. falciparum polypeptides of the invention, compositions comprising one or more placental P. falciparum polypeptides of the invention, methods for inducing an immune response against the placental P. falciparum polypeptides, and methods for treating and diagnosing placental malaria.

    摘要翻译: 本发明提供了分离的胎盘恶性疟原虫多肽,其包含选自SEQ ID NO:1-4和6-24的氨基酸序列及其免疫原性衍生物。 本发明还提供编码本发明的胎盘恶性疟原虫多肽的分离的核酸分子,包含本发明的一种或多种胎盘恶性疟原虫多肽的组合物,用于诱导针对胎盘恶性疟原虫多肽的免疫应答的方法,以及用于 治疗和诊断胎盘疟疾。

    Malaria Vaccines
    4.
    发明申请
    Malaria Vaccines 失效
    疟疾疫苗

    公开(公告)号:US20100172929A1

    公开(公告)日:2010-07-08

    申请号:US12633474

    申请日:2009-12-08

    摘要: The invention provides isolated placental P. falciparum polypeptides comprising an amino acid sequence selected from the group consisting of SEQ ID NOs:1-4 and 6-24, and immunogenic derivatives thereof. The invention also provides isolated nucleic acid molecules encoding the placental P. falciparum polypeptides of the invention, compositions comprising one or more placental P. falciparum polypeptides of the invention, methods for inducing an immune response against the placental P. falciparum polypeptides, and methods for treating and diagnosing placental malaria.

    摘要翻译: 本发明提供了分离的胎盘恶性疟原虫多肽,其包含选自SEQ ID NO:1-4和6-24的氨基酸序列及其免疫原性衍生物。 本发明还提供编码本发明的胎盘恶性疟原虫多肽的分离的核酸分子,包含本发明的一种或多种胎盘恶性疟原虫多肽的组合物,用于诱导针对胎盘恶性疟原虫多肽的免疫应答的方法,以及用于 治疗和诊断胎盘疟疾。

    Malaria vaccines
    5.
    发明申请
    Malaria vaccines 失效
    疟疾疫苗

    公开(公告)号:US20080213291A1

    公开(公告)日:2008-09-04

    申请号:US12006784

    申请日:2008-01-03

    摘要: The invention provides isolated placental P. falciparum polypeptides comprising an amino acid sequence selected from the group consisting of SEQ ID NOs:1-4 and 6-24, and immunogenic derivatives thereof. The invention also provides isolated nucleic acid molecules encoding the placental P. falciparum polypeptides of the invention, compositions comprising one or more placental P. falciparum polypeptides of the invention, methods for inducing an immune response against the placental P. falciparum polypeptides, and methods for treating and diagnosing placental malaria.

    摘要翻译: 本发明提供了分离的胎盘恶性疟原虫多肽,其包含选自SEQ ID NO:1-4和6-24的氨基酸序列及其免疫原性衍生物。 本发明还提供编码本发明的胎盘恶性疟原虫多肽的分离的核酸分子,包含本发明的一种或多种胎盘恶性疟原虫多肽的组合物,用于诱导针对胎盘恶性疟原虫多肽的免疫应答的方法,以及用于 治疗和诊断胎盘疟疾。